Insmed (INSM) Invested Capital (2011 - 2025)

Insmed's Invested Capital history runs 13 years deep, the most recent figure standing at $24.1 million for Q4 2025.

• On a quarterly basis, Invested Capital fell 10.96% year-over-year to $24.1 million in Q4 2025; TTM through Mar 2026 was $24.1 million, a 90.43% decrease from a year earlier, with the FY2025 full-year figure at $24.1 million, down 10.96% from the prior year.
• Invested Capital declined to $24.1 million in Q4 2025 per INSM's latest filing, from $27.0 million in the prior quarter.
• Across five years, Invested Capital topped out at $224.4 million in Q2 2024 and bottomed at $14.7 million in Q4 2021.
• The 5-year median for Invested Capital is $29.6 million (2023), against an average of $82.1 million.
• Across the five-year window, Invested Capital surged 109.71% in 2022 and decreased 10.96% in 2025, its largest moves.
• Year by year, Invested Capital stood at $14.7 million in 2021, then surged by 109.71% to $30.9 million in 2022, then declined by 3.94% to $29.6 million in 2023, then fell by 8.81% to $27.0 million in 2024, then declined by 10.96% to $24.1 million in 2025.
• Per Business Quant, the three latest INSM Invested Capital figures stand at $24.1 million (Q4 2025), $27.0 million (Q4 2024), and $224.4 million (Q2 2024).